Ro KhannaBuy
BSX Common Stock · Transaction Jul 20, 2026 · Filed Aug 7, 2026 · $1,001 to $15,000
XNYS · BSX
+0.27% · +$0.1300 · Vol Not reported
Pre-market · updated 04:01:03 ET
Boston Scientific Corp.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$48.50
Veridion Score
BETAHIGH CONF · 6 of 6 factors measuredWed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET · BSX
MethodologyBSX
Boston Scientific Corp.
Wed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
67/ 100
Veridion Score
Upper range · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Wed Sep 2 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BSX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Boston Scientific Corp.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1992
Employees
59K
Country
US
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$48.37
Last session
Day high
$48.37
Last session
Day low
$48.37
Last session
Previous close
$48.37
52W high
$108.14
-55.15% from high
52W low
$42.63
9% of range
Market cap
$70.1B
P/E
19.02×
EPS
$2.55
Beta
0.03
Shares out
1.4B
Avg volume
20.6M
VWAP
$48.37
Last session
Price history computed in-house
1W
+3.92%
1M
-1.20%
3M
-0.10%
1Y
-54.90%
YTD
-49.13%
SMA 50 $46.76 · above
SMA 200 $67.31 · below
52W position 9%
BSX overview
Related filings and maps
Public disclosures
Congress activity in BSX
Official filing ↗
Ro KhannaSell
BSX Common Stock · Transaction Jul 7, 2026 · Filed Aug 7, 2026 · $1,001 to $15,000
Ro KhannaBuy
BSX Common Stock · Transaction Jun 30, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
Ro KhannaSell
BSX Common Stock · Transaction Jun 16, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
BSX · Transaction Jun 5, 2026 · Filed Jul 2, 2026 · $1,001 to $15,000
Federal contracts
BSX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BSX in this window.
Lobbying spend
BSX lobbying filings, year to date.
Registered lobbying filings matched to Boston Scientific Corp..
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BSX in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BSX.
Options
Sovereign unlock shows live options positioning for BSX.